HUNTSVILLE, Ala.--(BUSINESS WIRE)--Open Biosystems, Inc., focused on the commercialization of leading-edge life science research tools for drug discovery, today announced the availability of its Expression Arrest™ GIPZ lentiviral shRNAmir libraries. Targeting the entire human genome with multiple shRNAmir constructs per gene, the GIPZ lentiviral shRNAmir library builds on Open Biosystems’ proven RNAi technologies that enable researchers to quickly realize the inherent value of RNAi.
